Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ05
- Pharmacological subgroupJ05A
- Chemical subgroupJ05AXOther antivirals
- Chemical substanceJ05AX28Bulevirtide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 2 registrations
Canada
Health Canada · 1 registration
European Union
EMA · 1 registration
Croatia
HALMED · 1 registration
At a glance
- ATC code
- J05AX28
- ATC group
- Anti-infectives for systemic use
- Registers
- 6
- Registrations
- 7
- With their own page
- 7
- Companies
- 4
All medicines with Bulevirtide
Human medicines from every register that match Bulevirtide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
7 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Hepcludex | United States | 8.5MG | injection | Marketed | Gilead Sciences INC |
| Hepcludex | European Union | Authorised | Gilead Sciences Ireland UC | ||
| Hepcludex 2 MG Polvo Para Solucion Inyectable | Spain | 2,022 mg | polvo para solución inyectable | Marketed | Gilead Sciences Ireland Unlimited Company |
| Hepcludex 2 mg poeder voor oplossing voor injectie | Netherlands | Poeder voor oplossing voor injectie | Authorised | Gilead Sciences Ireland UC | |
| Hepcludex 2 MG Polvo Para Solucion Inyectable | Spain | 2,022 mg | polvo para solución inyectable | Authorised | Gilead Sciences Ireland Unlimited Company |
| Hepcludex | Canada | 2 MG / VIAL | Powder For Solution | Marketed | Gilead Sciences Canada INC |
| Hepcludex | Croatia | Marketed |